ClinicalTrials.gg
RecruitingNCT06803069Updated Feb 19, 2025

Investigation of the Mechanisms of the Tendency to Hypothermia in Newborns and Premature Neonates

An observational study in Neonatal Hypothermia, Brown Adipose Tissue and Preterm and Term Infants, sponsored by University of Pecs. Recruiting at 2 sites in Hungary. Open to participants aged Up to 2 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-19.

Sponsored by University of Pecs · Observational

From the registry’s dates

  • Started Jul 2024; still recruiting 2 years 4 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
Up to 2 Years
Sex
All
01

Study summary

Newborns have thermoregulatory mechanisms that differ from those of adults. Instead of producing heat through shivering, newborns primarily rely on non-shivering thermogenesis by the brown adipose tissue. The development of this thermogenic tissue starts around the 26th gestational week and continues until shortly before birth, after which no further growth occurs. As a result, premature infants, who have less developed brown fat, are more prone to reduced heat production and are at higher risk for hypothermia. There are few human studies examining the thermoregulatory differences and mechanisms between full-term and premature neonates, and the findings remain inconclusive.

In this study, the investigators aim to conduct a prospective, observational research. Researchers will compare body temperature, brown adipose tissue activity, and specific plasma markers between full-term and premature neonates in insensive care units and during elective surgeries.

Read the detailed description

Test Methods:

Both substudies involve the use of a FLIR C3 mobile thermal camera to create thermograms. Thermal images of the full-term and preterm infants are taken from a distance of 20 cm while the participants lie in a supine position. The area examined spans from the upper edge of the diaper to the top of the head.

Substudy 1:

  1. a) In case of neonates in the intensive care unit or waiting for short procedures (e.g., ophthalmic surgery), thermal images are taken before transport to the operating room and after surgery, before transferring back to the ward. For infants receiving incubator care, both images are taken inside the transport incubator. The test duration is about 5 minutes.
  1. b) Images are captured before kangaroo care, before and after transferring the infant to the ward (both images taken in the transport incubator if the infant is in incubator care).
  1. c) Thermal images are taken before and after the insertion of an epicutaneous cannula.
  1. d) For post-asphyxic infants undergoing therapeutic hypothermia, images are taken immediately before starting cooling on the therapeutic mattress, once midway through the cooling process; once immediately after reaching the target core temperature; then daily while in the hypothermic state; once immediately before the rewarming process, and every hour during rewarming until the desired core temperature is reached.

    Substudy 2:

  2. a) In case of neonates waiting for surgeries lasting more than 30 minutes, thermal images are taken before the surgery; every 10 minutes during the operation; after surgery, following the same protocol as in Substudy 1.
  1. b) Thermal images are taken before and after inserting a central cannula.

Parameters recorded in the substudies:

  1. Blood tests, including c-reactive protein (CRP), procalcitonin (PCT), blood count, glucose, bilirubin, thyroid hormones, urea, creatinine, glutamate oxaloacetate transaminase (GOT), glutamate pyruvate transaminase (GPT), lactate dehydrogenase (LDH), gamma-glutamyl transferase (GGT), and blood gas, as part of routine blood sampling.
  2. Rectal core temperature, as well as episodes of shivering or heat production.
  3. Changes in body temperature during surgery along with other routinely measured physiological parameters (e.g., blood pressure, respiratory indicators).
  4. Type and dosage of anesthetics used, as well as any side effects (e.g., post-surgery vomiting).
  5. Additional parameters such as gestational age, Apgar score, birth weight, body weight at the time of examination, and environmental temperature (e.g., clinic, incubator, operating room).

Examination process:

The parents/guardians/legal representatives of the selected patients will be provided with detailed information, and consent forms will be signed by them.

02

Conditions studied

  • Neonatal Hypothermia
  • Brown Adipose Tissue
  • Preterm and Term Infants
  • Neonate
  • Thermogenesis
  • Blood Markers

Browse trials for

Keywords

  • brown adipose tissue
  • neonate
  • neonatal hypothermia
  • preterm
  • nonshivering thermogenesis
  • infant
  • newborn
03

In context

Premature Birth

2,550 studies on the registry are indexed under Premature Birth; 500 are open to participants now.

This study's planned enrollment of 100 is below the median of 120 across 806 observational studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

University of Pecs is the lead sponsor of 106 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 2 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Study population consist of randomly chosen preterm and full-term neonates.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • For Substudy 1: Patients admitted to the Neonatal Intensive Care Unit at the University of Pécs, Department of Obstetrics and Gynaecology (premature infants or those in neonatal intensive care).
  • For Substudy 2: Patients under 2 years of age undergoing elective surgery lasting more than 30 minutes at the University of Pécs, Department of Paediatrics.
  • For both substudies: Written consent for participation in the study has been provided by the patient's parent, guardian, or legal representative.

Exclusion criteria

Exclusion Criteria:

  • For both substudies: If the patient cannot be mobilized (e.g., during the post-operative phase of abdominal or thoracic surgery; presence of chest tubes for pneumothorax or other reasons; hemodynamic instability; need for continuous (ECG) monitoring; or use of an external pacemaker).
  • The patient's parent, guardian, or legal representative does not consent to the study or withdraws their consent at any point.
  • For Substudy 2: if the patient is older than 2 years.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Preterm neonates

    Group of neonates who were born before the 37th gestational week.

  • Full-term neonates

    Group of neonates who were born after the 37th gestational week.

06

What researchers measure

Primary outcomes

  1. Temperature data from the back of neonates revealing brown adipose tissue activity

    Primary objective (Primary endpoint): The thermogram analysis may reveal reduced brown adipose tissue activity in preterm infants, which could contribute to their increased susceptibility to hypothermia during surgeries and intensive care. The temperature values of the head, brown fat, and trunk will be recorded in degrees of Celsius (°C) with thermal imaging. Their difference (e.g., brown fat temperature minus trunk temperature) will be used as a measure of brown fat activity also expressed in °C.

    Time frame: 2 years

Secondary outcomes

  1. Concentration and count of special laboratory parameters in connection with thermogenesis in neonates

    Secondary objective (Secondary endpoint): Blood test parameters of the newborns will be determined by the accredited Medical Testing Laboratory at the Clinical Centre, University of Pecs. These include blood cell counts \[red blood cells (T/l), white blood cells (G/l), and platelets (G/l)\], hemoglobin (g/l), hematocrit (%), glucose (mmol/l), bilirubin (µmol/l), thyroid hormones (mIU/l), urea (µmol/l), creatinine (µmol/l), CRP (mg/l), AST (IU/l), ALT (IU/l), GGT (IU/l), LDH (IU/l), PCT (0,5 ng/ml). They will be used to assess correlations between brown fat activity (see Primary Outcome Measure) and blood levels of a given blood parameter.

    Time frame: 3 years

  2. Blood cell counts

    Level of red blood cells in T/l, white blood cells in G/l, and platelets in G/l.

    Time frame: 3 years

  3. Hemoglobin level

    Hemoglobin level in g/l

    Time frame: 3 years

  4. Hematocrit level

    Hematocrit level in %.

    Time frame: 3 years

  5. Glucose level

    Glucose level in mmol/l.

    Time frame: 3 years

  6. Liver fuction

    bilirubin in µmol/l, AST in IU/l, ALT in IU/l, GGT in IU/l, LDH in IU/l.

    Time frame: 3 years

  7. Kidney function

    urea in µmol/l, creatinine in µmol/l.

    Time frame: 3 years

  8. Thyroid function

    thyroid hormones in mIU/l (TSH, T3, T4).

    Time frame: 3 years

  9. Inflammatory markers

    CRP in mg/l and PCT in ng/ml.

    Time frame: 3 years

07

Study locations

2 of 2 sites recruiting
08

References and documents

Publications

  • Nedergaard J, Cannon B. Brown adipose tissue as a heat-producing thermoeffector. Handb Clin Neurol. 2018;156:137-152. doi: 10.1016/B978-0-444-63912-7.00009-6. PubMed 30454587 ↗
  • Symonds ME, Pope M, Sharkey D, Budge H. Adipose tissue and fetal programming. Diabetologia. 2012 Jun;55(6):1597-606. doi: 10.1007/s00125-012-2505-5. Epub 2012 Mar 9. PubMed 22402988 ↗
  • Lunze K, Hamer DH. Thermal protection of the newborn in resource-limited environments. J Perinatol. 2012 May;32(5):317-24. doi: 10.1038/jp.2012.11. Epub 2012 Mar 1. PubMed 22382859 ↗
  • Silverman WA, Sinclair JC. Temperature regulation in the newborn infant. N Engl J Med. 1966 Jan 13;274(2):92-4 contd. doi: 10.1056/NEJM196601132740207. No abstract available. PubMed 5322157 ↗
  • Knobel R, Holditch-Davis D. Thermoregulation and heat loss prevention after birth and during neonatal intensive-care unit stabilization of extremely low-birthweight infants. J Obstet Gynecol Neonatal Nurs. 2007 May-Jun;36(3):280-7. doi: 10.1111/j.1552-6909.2007.00149.x. PubMed 17489935 ↗
  • Lidell ME. Brown Adipose Tissue in Human Infants. Handb Exp Pharmacol. 2019;251:107-123. doi: 10.1007/164_2018_118. PubMed 29675580 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Sep 2027, 38 months after the start.

Of 372 non-industry observational studies under Premature Birth, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 63. This study's planned 38 months is close to that.

Counting every sponsor, half of 387 studies reached it within 35 months; a quarter within 18 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 25, 2025
First posted
Jan 31, 2025
StartActual
Jul 1, 2024
Primary completionEst.
Sep 2027
CompletionEst.
Jul 1, 2029
Last update
Feb 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06803069
Lead sponsor
University of Pecs
Responsible party
Sponsor
First posted
Jan 31, 2025
Start date
Jul 1, 2024
Primary completion
Sep 2027 (estimated)
Completion
Jul 1, 2029 (estimated)
Last update
Feb 19, 2025

Study contacts

András Garami, MD, PhD
Contact
andras.garami@aok.pte.hu
+3672536000 ext. 38607
Kata Fekete, MSc
Contact
kata.fekete@aok.pte.hu
+3672536000 ext. 38604
Tamás Kövesi, MD, PhD
principal investigator · University of Pecs, Department of Anaesthesiology and Intensive Therapy
András Garami, MD, PhD
principal investigator · University of Pecs, Institute for Translational Medicine
Simone Funke, MD, PhD
principal investigator · University of Pecs, Department of Obstetrics and Gynaecology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion